Capital Health Partners completed the acquisition of Calea from Fresenius Kabi.

Capital Health Partners, a distributor of medical supplies, equipment, and pharmaceuticals, completed the acquisition of Calea, a healthcare company from Fresenius Kabi, a healthcare company specializing in lifesaving medicines and technologies. Financial terms were not disclosed. “Calea’s clinical leadership, national reach, and decades of experience make it a perfect fit for our vision. Together, we are building a stronger, more innovative healthcare network that delivers exceptional care directly to patients’ homes,” Yves Portelance, Capital Health Partners CEO.